Compare BRAG & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRAG | ATRA |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5M | 38.9M |
| IPO Year | 2021 | 2014 |
| Metric | BRAG | ATRA |
|---|---|---|
| Price | $1.53 | $6.28 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | 25.7K | ★ 156.4K |
| Earning Date | 01-01-0001 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.93 |
| Revenue | N/A | ★ $128,940,000.00 |
| Revenue This Year | $6.63 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.79 |
| Revenue Growth | N/A | ★ 1404.02 |
| 52 Week Low | $1.46 | $3.92 |
| 52 Week High | $4.82 | $19.15 |
| Indicator | BRAG | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 29.22 | 53.73 |
| Support Level | N/A | $4.06 |
| Resistance Level | $2.77 | $13.04 |
| Average True Range (ATR) | 0.14 | 0.66 |
| MACD | -0.00 | 0.38 |
| Stochastic Oscillator | 12.99 | 64.35 |
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).